摘要
目的：探讨恩度肝动脉灌注联合介入化疗栓塞治疗中晚期肝癌的临床疗效.方法：按照贯序法将48例原发性肝癌患者随机分为观察组和对照组,其中观察组采用恩度肝动脉灌注联合介入化疗栓塞治疗,并与单独采用介入化疗栓塞治疗的对照组进行临床疗效比较.结果：经过积极的治疗,观察组的总有效率明显高于对照组,且差异具有统计学意义（P〈0.05）;另外,两组的不良反应相似,无明显差异（P〉0.05）.结论：恩度肝动脉灌注联合介入化疗栓塞治疗中晚期肝癌是一有效的治疗方法,值得在临床中推广和进一步研究.
Objective：To evaluate the degree of hepatic artery perfusion ex chemoembolization combined interventional treatment of advanced liver cancer patients. Methods： Sequential method in accordance with 48 cases of primary liver cancer were randomly divided into two groups and the control group, which group was observed Endostar interventional hepatic arterial infusion chemotherapy combined embolization and chemoembolization alone interventional therapy control group Comparison of clinical efficacy. Results： After active treatment,the total effective observation group was significantly higher,and the difference was significant （P 〈0.05）; In addition,adverse effects were similar in both groups, no significant difference （P〉 0.05）. Conclusion： Hepatic arterial infusion combined Endostar interventional treatment of advanced hepatocellular carcinoma chemoembolization is an effective method of treatment,in clinical studies to promote and further.
出处
《按摩与康复医学》
2011年第9期11-12,共2页
Chinese Manipulation and Rehabilitation Medicine
关键词
恩度
经肝动脉化疗栓塞术
肝癌
Endostar Transcatheter arterial chemoembolization Hepatic carcinoma
